标题
Improving the Efficiency of Vγ9Vδ2 T-Cell Immunotherapy in Cancer
作者
关键词
-
出版物
Frontiers in Immunology
Volume 9, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2018-04-19
DOI
10.3389/fimmu.2018.00800
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Immune cells regulate VEGF signalling via release of VEGF and antagonistic soluble VEGF receptor-1
- (2018) T. Hoeres et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- NKG2D ligands in glioma stem-like cells: expression in situ and in vitro
- (2018) Charlotte Flüh et al. HISTOCHEMISTRY AND CELL BIOLOGY
- The butyrophilin 3A1 intracellular domain undergoes a conformational change involving the juxtamembrane region
- (2017) Khiem Nguyen et al. FASEB JOURNAL
- Phosphoantigen-induced conformational change of butyrophilin 3A1 (BTN3A1) and its implication on Vγ9Vδ2 T cell activation
- (2017) Siyi Gu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- CD20-Specific Immunoligands Engaging NKG2D Enhance γδ T Cell-Mediated Lysis of Lymphoma Cells
- (2017) M. Peipp et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- The ATP-binding cassette transporter A1 regulates phosphoantigen release and Vγ9Vδ2 T cell activation by dendritic cells
- (2017) Barbara Castella et al. Nature Communications
- Expression of LAG-3 defines exhaustion of intratumoral PD-1+ T cells and correlates with poor outcome in follicular lymphoma
- (2017) Zhi-Zhang Yang et al. Oncotarget
- Squamous Cell Tumors Recruit γδ T Cells Producing either IL17 or IFNγ Depending on the Tumor Stage
- (2017) Elena Lo Presti et al. Cancer Immunology Research
- PD-1 and PD-L1 Checkpoint Signaling Inhibition for Cancer Immunotherapy: Mechanism, Combinations, and Clinical Outcome
- (2017) Hashem O. Alsaab et al. Frontiers in Pharmacology
- What Else Can CD39 Tell Us?
- (2017) Hai Zhao et al. Frontiers in Immunology
- Metabolic Hallmarks of Tumor and Immune Cells in the Tumor Microenvironment
- (2017) Kathrin Renner et al. Frontiers in Immunology
- Current Advances in γδ T Cell-Based Tumor Immunotherapy
- (2017) Elena Lo Presti et al. Frontiers in Immunology
- Combining Vγ9Vδ2 T Cells with a Lipophilic Bisphosphonate Efficiently Kills Activated Hepatic Stellate Cells
- (2017) Xiaoying Zhou et al. Frontiers in Immunology
- Mevalonate metabolism governs cancer immune surveillance
- (2017) Georg Gruenbacher et al. OncoImmunology
- Assessment of tumor-infiltrating TCRVγ9Vδ2 γδ lymphocyte abundance by deconvolution of human cancers microarrays
- (2017) Marie Tosolini et al. OncoImmunology
- Distinctive features of tumor-infiltrating γδ T lymphocytes in human colorectal cancer
- (2017) S. Meraviglia et al. OncoImmunology
- Enhancing adoptive cancer immunotherapy with Vγ2Vδ2 T cells through pulse zoledronate stimulation
- (2017) Mohanad H. Nada et al. Journal for ImmunoTherapy of Cancer
- Vδ2+ T cell response to malaria correlates with protection from infection but is attenuated with repeated exposure
- (2017) Prasanna Jagannathan et al. Scientific Reports
- Anti-Tumor Activity and Immunotherapeutic Potential of a Bisphosphonate Prodrug
- (2017) Yoshimasa Tanaka et al. Scientific Reports
- γδ T Cells Support Pancreatic Oncogenesis by Restraining αβ T Cell Activation
- (2016) Donnele Daley et al. CELL
- Targeting Cancer Cells with a Bisphosphonate Prodrug
- (2016) Kenji Matsumoto et al. ChemMedChem
- Highly specific and potently activating Vγ9Vδ2-T cell specific nanobodies for diagnostic and therapeutic applications
- (2016) Renée C.G. de Bruin et al. CLINICAL IMMUNOLOGY
- Proportions of blood-borne Vδ1+ and Vδ2+ T-cells are associated with overall survival of melanoma patients treated with ipilimumab
- (2016) Kilian Wistuba-Hamprecht et al. EUROPEAN JOURNAL OF CANCER
- Regulatory and effector functions of gamma-delta (γδ) T cells and their therapeutic potential in adoptive cellular therapy for cancer
- (2016) Sourav Paul et al. INTERNATIONAL JOURNAL OF CANCER
- Membrane-bound versus soluble major histocompatibility complex Class I-related chain A and major histocompatibility complex Class I-related chain B differential expression: Mechanisms of tumor eradication versus evasion and current drug development strategies
- (2016) PK Suresh Journal of Cancer Research and Therapeutics
- HMBPP Analog Prodrugs Bypass Energy-Dependent Uptake To Promote Efficient BTN3A1-Mediated Malignant Cell Lysis by Vγ9Vδ2 T Lymphocyte Effectors
- (2016) Ashley M. Kilcollins et al. JOURNAL OF IMMUNOLOGY
- Prevention of Vγ9Vδ2 T Cell Activation by a Vγ9Vδ2 TCR Nanobody
- (2016) Renée C. G. de Bruin et al. JOURNAL OF IMMUNOLOGY
- Prolonged PD1 Expression on Neonatal Vδ2 Lymphocytes Dampens Proinflammatory Responses: Role of Epigenetic Regulation
- (2016) Haoting Hsu et al. JOURNAL OF IMMUNOLOGY
- Inversion of the Vδ1 to Vδ2 γδ T cell ratio in CVID is not restored by IVIg and is associated with immune activation and exhaustion
- (2016) Dominic Paquin-Proulx et al. MEDICINE
- In vivo expansion and activation of γδ T cells as immunotherapy for refractory neuroblastoma
- (2016) Joseph G. Pressey et al. MEDICINE
- Emerging concepts of T cell metabolism as a target of immunotherapy
- (2016) Chih-Hao Chang et al. NATURE IMMUNOLOGY
- Molecular and Biochemical Aspects of the PD-1 Checkpoint Pathway
- (2016) Vassiliki A. Boussiotis NEW ENGLAND JOURNAL OF MEDICINE
- Bisphosphonates for cancer treatment: Mechanisms of action and lessons from clinical trials
- (2016) Heleen H. Van Acker et al. PHARMACOLOGY & THERAPEUTICS
- Heterogeneous yet stable Vδ2(+)T-cell profiles define distinct cytotoxic effector potentials in healthy human individuals
- (2016) Paul L. Ryan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Adaptive resistance to therapeutic PD-1 blockade is associated with upregulation of alternative immune checkpoints
- (2016) Shohei Koyama et al. Nature Communications
- Low-dose bortezomib increases the expression of NKG2D and DNAM-1 ligands and enhances induced NK and γδ T cell-mediated lysis in multiple myeloma
- (2016) Chao Niu et al. Oncotarget
- CD19-specific triplebody SPM-1 engages NK and γδ T cells for rapid and efficient lysis of malignant B-lymphoid cells
- (2016) Christian B. Schiller et al. Oncotarget
- Ecto-ATPase CD39 Inactivates Isoprenoid-Derived Vγ9Vδ2 T Cell Phosphoantigens
- (2016) Georg Gruenbacher et al. Cell Reports
- RhoB Mediates Phosphoantigen Recognition by Vγ9Vδ2 T Cell Receptor
- (2016) Zsolt Sebestyen et al. Cell Reports
- Stereotaxic administrations of allogeneic human Vγ9Vδ2 T cells efficiently control the development of human glioblastoma brain tumors
- (2016) Ulrich Jarry et al. OncoImmunology
- BTN3A molecules considerably improve Vγ9Vδ2T cells-based immunotherapy in acute myeloid leukemia
- (2016) Audrey Benyamine et al. OncoImmunology
- In vitro analysis of the proliferative capacity and cytotoxic effects of ex vivo induced natural killer cells, cytokine-induced killer cells, and gamma-delta T cells
- (2015) Chao Niu et al. BMC IMMUNOLOGY
- γδ T cell activation by bispecific antibodies
- (2015) Hans-Heinrich Oberg et al. CELLULAR IMMUNOLOGY
- Evolution and function of the TCR Vgamma9 chain repertoire: It’s good to be public
- (2015) C. David Pauza et al. CELLULAR IMMUNOLOGY
- VEGF-A modulates expression of inhibitory checkpoints on CD8+T cells in tumors
- (2015) Thibault Voron et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Sensor Function for Butyrophilin 3A1 in Prenyl Pyrophosphate Stimulation of Human Vγ2Vδ2 T Cells
- (2015) Hong Wang et al. JOURNAL OF IMMUNOLOGY
- IL-17-producing γδ T cells and neutrophils conspire to promote breast cancer metastasis
- (2015) Seth B. Coffelt et al. NATURE
- The prognostic landscape of genes and infiltrating immune cells across human cancers
- (2015) Andrew J Gentles et al. NATURE MEDICINE
- Effector Vγ9Vδ2 T cells dominate the human fetal γδ T-cell repertoire
- (2015) Tanya Dimova et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Tissue-based map of the human proteome
- (2015) M. Uhlen et al. SCIENCE
- Vγ9Vδ2 T cells and zoledronate mediate antitumor activity in an orthotopic mouse model of human chondrosarcoma
- (2015) L. Sun et al. TUMOR BIOLOGY
- Five Layers of Receptor Signaling in γδ T-Cell Differentiation and Activation
- (2015) Sérgio T. Ribeiro et al. Frontiers in Immunology
- γδ T cells and epigenetic drugs: A useful merger in cancer immunotherapy?
- (2015) Jaydeep Bhat et al. OncoImmunology
- Effective combination treatment of GD2-expressing neuroblastoma and Ewing's sarcoma using anti-GD2 ch14.18/CHO antibody with Vγ9Vδ2+ γδT cells
- (2015) Jonathan P H Fisher et al. OncoImmunology
- Resistance of cyclooxygenase-2 expressing pancreatic ductal adenocarcinoma cells against γδ T cell cytotoxicity
- (2015) Daniel Gonnermann et al. OncoImmunology
- NKG2D- and T-cell receptor-dependent lysis of malignant glioma cell lines by human γδ T cells: Modulation by temozolomide and A disintegrin and metalloproteases 10 and 17 inhibitors
- (2015) Guranda Chitadze et al. OncoImmunology
- PD-L1 expression in metastatic neuroblastoma as an additional mechanism for limiting immune surveillance
- (2015) Alessandra Dondero et al. OncoImmunology
- Anergic bone marrow Vγ9Vδ2 T cells as early and long-lasting markers of PD-1-targetable microenvironment-induced immune suppression in human myeloma
- (2015) Barbara Castella et al. OncoImmunology
- Opportunities and challenges in development of phosphoantigens as Vγ9Vδ2 T cell agonists
- (2014) David F. Wiemer et al. BIOCHEMICAL PHARMACOLOGY
- Dichloroacetate and cancer: New home for an orphan drug?
- (2014) Shyam Kankotia et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Targeted Activation of Human Vγ9Vδ2-T Cells Controls Epstein-Barr Virus-Induced B Cell Lymphoproliferative Disease
- (2014) Zheng Xiang et al. CANCER CELL
- Novel Bispecific Antibodies Increase T-Cell Cytotoxicity against Pancreatic Cancer Cells
- (2014) H.-H. Oberg et al. CANCER RESEARCH
- MICA polymorphism: biology and importance in cancer
- (2014) D. Chen et al. CARCINOGENESIS
- Synthesis of a Phosphoantigen Prodrug that Potently Activates Vγ9Vδ2 T-Lymphocytes
- (2014) Chia-Hung Christine Hsiao et al. CHEMISTRY & BIOLOGY
- Neuroblastoma Killing Properties of V 2 and V 2-Negative T Cells Following Expansion by Artificial Antigen-Presenting Cells
- (2014) J. P. H. Fisher et al. CLINICAL CANCER RESEARCH
- Programmed death-1 pathway in cancer and autoimmunity
- (2014) Ariel Pedoeem et al. CLINICAL IMMUNOLOGY
- Upregulation of NKG2D ligands in acute lymphoblastic leukemia and non-Hodgkin lymphoma cells by romidepsin and enhanced in vitro and in vivo natural killer cell cytotoxicity
- (2014) Prakash Satwani et al. CYTOTHERAPY
- γδT17 Cells Promote the Accumulation and Expansion of Myeloid-Derived Suppressor Cells in Human Colorectal Cancer
- (2014) Pin Wu et al. IMMUNITY
- The Intracellular B30.2 Domain of Butyrophilin 3A1 Binds Phosphoantigens to Mediate Activation of Human Vγ9Vδ2 T Cells
- (2014) Andrew Sandstrom et al. IMMUNITY
- Vγ9 and Vδ2 T cell antigen receptor genes and butyrophilin 3 (BTN3) emerged with placental mammals and are concomitantly preserved in selected species like alpaca (Vicugna pacos)
- (2014) Mohindar M. Karunakaran et al. IMMUNOGENETICS
- Phosphoantigens and butyrophilin 3A1 induce similar intracellular activation signaling in human TCRVγ9+ γδ T lymphocytes
- (2014) Emilie Decaup et al. IMMUNOLOGY LETTERS
- Metabolic Engineering ofSalmonellaVaccine Bacteria To Boost Human Vγ2Vδ2 T Cell Immunity
- (2014) Grefachew Workalemahu et al. JOURNAL OF IMMUNOLOGY
- IL-2: The First Effective Immunotherapy for Human Cancer
- (2014) S. A. Rosenberg JOURNAL OF IMMUNOLOGY
- A Comprehensive Analysis of Primary Acute Myeloid Leukemia Identifies Biomarkers Predicting Susceptibility to Human Allogeneic Vγ9Vδ2 T Cells
- (2014) Stefan Gundermann et al. JOURNAL OF IMMUNOTHERAPY
- Successful adoptive transfer and in vivo expansion of haploidentical γδ T cells
- (2014) Martin Wilhelm et al. Journal of Translational Medicine
- Murine CD27(-) V 6(+) T cells producing IL-17A promote ovarian cancer growth via mobilization of protumor small peritoneal macrophages
- (2014) M. Rei et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Intraperitoneal injection of in vitro expanded Vγ9Vδ2 T cells together with zoledronate for the treatment of malignant ascites due to gastric cancer
- (2014) Ikuo Wada et al. Cancer Medicine
- The Vγ9Vδ2 T Cell Antigen Receptor and Butyrophilin-3 A1: Models of Interaction, the Possibility of Co-Evolution, and the Case of Dendritic Epidermal T Cells
- (2014) Mohindar M. Karunakaran et al. Frontiers in Immunology
- Potential Use of γδ T Cell-Based Vaccines in Cancer Immunotherapy
- (2014) Mohd Wajid A. Khan et al. Frontiers in Immunology
- γδ T Cell-Mediated Antibody-Dependent Cellular Cytotoxicity with CD19 Antibodies Assessed by an Impedance-Based Label-Free Real-Time Cytotoxicity Assay
- (2014) Ursula Jördis Eva Seidel et al. Frontiers in Immunology
- Plasticity of γδ T Cells: Impact on the Anti-Tumor Response
- (2014) Virginie Lafont et al. Frontiers in Immunology
- Tumor-Infiltrating γδ T Lymphocytes: Pathogenic Role, Clinical Significance, and Differential Programing in the Tumor Microenvironment
- (2014) Elena Lo Presti et al. Frontiers in Immunology
- γδ T cells for cancer immunotherapy
- (2014) Jonathan PH Fisher et al. OncoImmunology
- Stress-related and homeostatic cytokines regulate Vγ9Vδ2 T-cell surveillance of mevalonate metabolism
- (2014) Georg Gruenbacher et al. OncoImmunology
- The co-receptor BTLA negatively regulates human V 9V 2 T-cell proliferation: a potential way of immune escape for lymphoma cells
- (2013) J. Gertner-Dardenne et al. BLOOD
- Human CD3γ, but not CD3δ, haploinsufficiency differentially impairs γδ versus αβ surface TCR expression
- (2013) Miguel Muñoz-Ruiz et al. BMC IMMUNOLOGY
- Comparison of γδ T cell responses and farnesyl diphosphate synthase inhibition in tumor cells pretreated with zoledronic acid
- (2013) Atif S. M. Idrees et al. CANCER SCIENCE
- Neutrophil uptake of nitrogen-bisphosphonates leads to the suppression of human peripheral blood γδ T cells
- (2013) Shirin Kalyan et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Phenotype and regulation of immunosuppressive Vδ2-expressing γδ T cells
- (2013) Christian Peters et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Ex vivo characterization of γδ T-cell repertoire in patients after adoptive transfer of Vγ9Vδ2 T cells expressing the interleukin-2 receptor β-chain and the common γ-chain
- (2013) Takamichi Izumi et al. CYTOTHERAPY
- Combination of radiofrequency ablation and sequential cellular immunotherapy improves progression-free survival for patients with hepatocellular carcinoma
- (2013) Jiuwei Cui et al. INTERNATIONAL JOURNAL OF CANCER
- Human Vγ2Vδ2 T cells limit breast cancer growth by modulating cell survival-, apoptosis-related molecules and microenvironment in tumors
- (2013) Reeva Aggarwal et al. INTERNATIONAL JOURNAL OF CANCER
- Repeated Systemic Administrations of Both Aminobisphosphonates and Human V 9V 2 T Cells Efficiently Control Tumor Development In Vivo
- (2013) T. Santolaria et al. JOURNAL OF IMMUNOLOGY
- Butyrophilin 3A1 Plays an Essential Role in Prenyl Pyrophosphate Stimulation of Human V 2V 2 T Cells
- (2013) H. Wang et al. JOURNAL OF IMMUNOLOGY
- Butyrophilin 3A1 binds phosphorylated antigens and stimulates human γδ T cells
- (2013) Stefano Vavassori et al. NATURE IMMUNOLOGY
- Engineered Drug Resistant γδ T Cells Kill Glioblastoma Cell Lines during a Chemotherapy Challenge: A Strategy for Combining Chemo- and Immunotherapy
- (2013) Lawrence S. Lamb et al. PLoS One
- Chemotherapy Sensitizes Colon Cancer Initiating Cells to Vγ9Vδ2 T Cell-Mediated Cytotoxicity
- (2013) Matilde Todaro et al. PLoS One
- Dysfunctional V 9V 2 T cells are negative prognosticators and markers of dysregulated mevalonate pathway activity in chronic lymphocytic leukemia cells
- (2012) M. Coscia et al. BLOOD
- Key implication of CD277/butyrophilin-3 (BTN3A) in cellular stress sensing by a major human T-cell subset
- (2012) C. Harly et al. BLOOD
- Long-Term Effects of Amino-Bisphosphonates on Circulating γδ T Cells
- (2012) Maurizio Rossini et al. CALCIFIED TISSUE INTERNATIONAL
- The functional impairment of HCC-infiltrating γδ T cells, partially mediated by regulatory T cells in a TGFβ- and IL-10-dependent manner
- (2012) Yong Yi et al. JOURNAL OF HEPATOLOGY
- Tumor-Infiltrating T Lymphocytes Predict Clinical Outcome in Human Breast Cancer
- (2012) C. Ma et al. JOURNAL OF IMMUNOLOGY
- Tumor-promoting Versus Tumor-antagonizing Roles of γδ T Cells in Cancer Immunotherapy
- (2012) Volker Kunzmann et al. JOURNAL OF IMMUNOTHERAPY
- Dacarbazine-Mediated Upregulation of NKG2D Ligands on Tumor Cells Activates NK and CD8 T Cells and Restrains Melanoma Growth
- (2012) Alice Hervieu et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- The activity of γδ T cells against paediatric liver tumour cells and spheroids in cell culture
- (2012) Alexander Hoh et al. LIVER INTERNATIONAL
- Adverse Effects of Bisphosphonates: Implications for Osteoporosis Management
- (2012) Kurt A. Kennel et al. MAYO CLINIC PROCEEDINGS
- Characterization of Human γδ T Lymphocytes Infiltrating Primary Malignant Melanomas
- (2012) Adriana Cordova et al. PLoS One
- Redirecting T cells against cancer cells by transfer of a broadly tumor-reactive T-cell receptor
- (2011) V. Marcu-Malina et al. BLOOD
- Differentiation, phenotype, and function of interleukin-17-producing human V 9V 2 T cells
- (2011) N. Caccamo et al. BLOOD
- Clinical evaluation of autologous gamma delta T cell-based immunotherapy for metastatic solid tumours
- (2011) A J Nicol et al. BRITISH JOURNAL OF CANCER
- Phase I/II study of adoptive transfer of γδ T cells in combination with zoledronic acid and IL-2 to patients with advanced renal cell carcinoma
- (2011) Hirohito Kobayashi et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Pilot trial of interleukin-2 and zoledronic acid to augment γδ T cells as treatment for patients with refractory renal cell carcinoma
- (2011) Joshua M. Lang et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Cancer Immunotherapy Using a Bispecific NK Receptor Fusion Protein that Engages both T Cells and Tumor Cells
- (2011) T. Zhang et al. CANCER RESEARCH
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Differential role for CD277 as a co-regulator of the immune signal in T and NK cells
- (2011) Nassima Messal et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- The gene expression profile of phosphoantigen-specific humanγδT lymphocytes is a blend of αβ T-cell and NK-cell signatures
- (2011) Fréderic Pont et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Upregulation of NKG2D ligands and enhanced natural killer cell cytotoxicity by hydralazine and valproate
- (2011) A. Due�as-Gonz�lez INTERNATIONAL JOURNAL OF ONCOLOGY
- Stimulated T Cells Increase the In Vivo Efficacy of Trastuzumab in HER-2+ Breast Cancer
- (2011) A.-H. Capietto et al. JOURNAL OF IMMUNOLOGY
- Adoptive Immunotherapy for Advanced Non-small CellLung Cancer Using Zoledronate-expanded γδTCells
- (2011) Miki Sakamoto et al. JOURNAL OF IMMUNOTHERAPY
- Anti-Leukemia Activity of In Vitro-Expanded Human Gamma Delta T Cells in a Xenogeneic Ph+ Leukemia Model
- (2011) Gabrielle M. Siegers et al. PLoS One
- Evolution of the V, D, and J gene segments used in the primate T-cell receptor reveals a dichotomy of conservation and diversity
- (2011) A. R. Kazen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- An NKG2D-Mediated Human Lymphoid Stress Surveillance Response with High Interindividual Variation
- (2011) S. Shafi et al. Science Translational Medicine
- Effect of vascular endothelial growth factor and its receptor KDR on the transendothelial migration and local trafficking of human T cells in vitro and in vivo
- (2010) M. Edelbauer et al. BLOOD
- Increasing the efficacy of CD20 antibody therapy through the engineering of a new type II anti-CD20 antibody with enhanced direct and immune effector cell-mediated B-cell cytotoxicity
- (2010) E. Mossner et al. BLOOD
- Phase I study of bromohydrin pyrophosphate (BrHPP, IPH 1101), a Vγ9Vδ2 T lymphocyte agonist in patients with solid tumors
- (2010) Jaafar Bennouna et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- In vivo manipulation of Vγ9Vδ2 T cells with zoledronate and low-dose interleukin-2 for immunotherapy of advanced breast cancer patients
- (2010) S. Meraviglia et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Zoledronate-activated Vγ9γδ T cell-based immunotherapy is feasible and restores the impairment of γδ T cells in patients with solid tumors
- (2010) Atsutaka Noguchi et al. CYTOTHERAPY
- A phase I study of adoptive immunotherapy for recurrent non-small-cell lung cancer patients with autologous γδ T cells☆☆☆
- (2010) Jun Nakajima et al. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
- Tumor-infiltrating IL-17-producing γδ T cells support the progression of tumor by promoting angiogenesis
- (2010) Daiko Wakita et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Expression and function of PD-1 in human γδ T cells that recognize phosphoantigens
- (2010) Masashi Iwasaki et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- T-cell killing of primary follicular lymphoma cells is dramatically potentiated by GA101, a type II glycoengineered anti-CD20 monoclonal antibody
- (2010) M. S. Braza et al. HAEMATOLOGICA
- Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity
- (2010) Kaori Sakuishi et al. JOURNAL OF EXPERIMENTAL MEDICINE
- V 9V 2 T Lymphocytes Efficiently Recognize and Kill Zoledronate-Sensitized, Imatinib-Sensitive, and Imatinib-Resistant Chronic Myelogenous Leukemia Cells
- (2010) M. D'Asaro et al. JOURNAL OF IMMUNOLOGY
- V 2V 2 T Cell Receptor Recognition of Prenyl Pyrophosphates Is Dependent on All CDRs
- (2010) H. Wang et al. JOURNAL OF IMMUNOLOGY
- Cytokine Requirements for the Differentiation and Expansion of IL-17A- and IL-22-Producing Human V 2V 2 T Cells
- (2010) K. J. Ness-Schwickerath et al. JOURNAL OF IMMUNOLOGY
- First-line treatment with zoledronic acid as compared with clodronic acid in multiple myeloma (MRC Myeloma IX): a randomised controlled trial
- (2010) Gareth J Morgan et al. LANCET
- Lipophilic Pyridinium Bisphosphonates: Potent γδT Cell Stimulators
- (2009) Yonghui Zhang et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Bromohydrin pyrophosphate enhances antibody-dependent cell-mediated cytotoxicity induced by therapeutic antibodies
- (2009) J. Gertner-Dardenne et al. BLOOD
- The NKG2D ligand ULBP4 binds to TCR 9/ 2 and induces cytotoxicity to tumor cells through both TCR and NKG2D
- (2009) Y. Kong et al. BLOOD
- Adoptively transferred ex vivo expanded γδ-T cells mediate in vivo antitumor activity in preclinical mouse models of breast cancer
- (2009) Benjamin H. Beck et al. BREAST CANCER RESEARCH AND TREATMENT
- DNAX accessory molecule-1 (CD226) promotes human hepatocellular carcinoma cell lysis by Vγ9Vδ2 T cells
- (2009) Olivier Toutirais et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Defective γδ T-cell function and granzyme B gene polymorphism in a cohort of newly diagnosed breast cancer patients
- (2009) Ameera Gaafar et al. EXPERIMENTAL HEMATOLOGY
- Clinical and immunological evaluation of zoledronate-activated Vγ9γδ T-cell-based immunotherapy for patients with multiple myeloma
- (2009) Yu Abe et al. EXPERIMENTAL HEMATOLOGY
- NKG2D and its ligands
- (2009) Peyman Obeidy et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Analysis of endogenous ATP analogs and mevalonate pathway metabolites in cancer cell cultures using liquid chromatography–electrospray ionization mass spectrometry
- (2009) Marjo Jauhiainen et al. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES
- Serum Vascular Endothelial Growth Factor and Fibronectin Predict Clinical Response to High-Dose Interleukin-2 Therapy
- (2009) Marianna Sabatino et al. JOURNAL OF CLINICAL ONCOLOGY
- Efficient Killing of Human Colon Cancer Stem Cells by T Lymphocytes
- (2009) M. Todaro et al. JOURNAL OF IMMUNOLOGY
- Chemokine Receptors Expression and Migration Potential of Tumor-infiltrating and Peripheral-expanded Vγ9Vδ2 T Cells From Renal Cell Carcinoma Patients
- (2009) Emilie Viey et al. JOURNAL OF IMMUNOTHERAPY
- Immunoactivation in preeclampsia: Vδ2+ and regulatory T cells during the inflammatory stage of disease
- (2009) Eva Miko et al. JOURNAL OF REPRODUCTIVE IMMUNOLOGY
- Peripheral blood monocytes are responsible for γδ T cell activation induced by zoledronic acid through accumulation of IPP/DMAPP
- (2008) Anke J. Roelofs et al. BRITISH JOURNAL OF HAEMATOLOGY
- Phase-I study of Innacell γδ™, an autologous cell-therapy product highly enriched in γ9δ2 T lymphocytes, in combination with IL-2, in patients with metastatic renal cell carcinoma
- (2008) Jaafar Bennouna et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- CD16+ γδ T cells mediate antibody dependent cellular cytotoxicity: Potential mechanism in the pathogenesis of multiple sclerosis
- (2008) Zhihong Chen et al. CLINICAL IMMUNOLOGY
- Vγ9Vδ2 T cell cytotoxicity against tumor cells is enhanced by monoclonal antibody drugs—Rituximab and trastuzumab
- (2008) Hirotake Tokuyama et al. INTERNATIONAL JOURNAL OF CANCER
- Design, Synthesis, and Biological Evaluation of Novel Aminobisphosphonates Possessing an in Vivo Antitumor Activity Through a γδ-T Lymphocytes-Mediated Activation Mechanism
- (2008) Daniele Simoni et al. JOURNAL OF MEDICINAL CHEMISTRY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now